Rani Therapeutics Holdings, Inc. (RANI)

Last Closing Price: 0.65 (2026-11-18)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Rani Therapeutics Holdings, Inc. (RANI) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$1.71M
$-7.73M
Cost of Goods Sold
--
$1.71M
$10.93M
$-9.22M
$0.42M
$-8.81M
$-8.81M
$-8.81M
$-8.81M
$-8.81M
$-8.81M
$-9.22M
$-9.32M
199.01M
199.01M
$-0.04
$-0.04
Balance Sheet Financials
$48.48M
$0.66M
$4.05M
$52.53M
$9.22M
--
$1.95M
$11.18M
$41.35M
$41.35M
$41.35M
139.46M
Cash Flow Statement Financials
$-23.28M
$-10.15M
$18.43M
$18.82M
$3.82M
$-15.00M
$6.72M
--
--
Fundamental Metrics & Ratios
5.26
--
--
--
--
100.00%
-540.30%
-540.30%
--
-515.88%
-452.78%
$-23.51M
--
--
--
0.03
--
0.87
103.34
-21.29%
-21.29%
-16.76%
-21.29%
$0.30
$-0.12
$-0.12